KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) EPS (Weighted Average and Diluted): 2020-2025

Historic EPS (Weighted Average and Diluted) for Twist Bioscience (TWST) over the last 6 years, with Sep 2025 value amounting to -$1.30.

  • Twist Bioscience's EPS (Weighted Average and Diluted) rose 23.73% to -$0.45 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.31, marking a year-over-year increase of 63.61%. This contributed to the annual value of -$1.30 for FY2025, which is 63.89% up from last year.
  • According to the latest figures from FY2025, Twist Bioscience's EPS (Weighted Average and Diluted) is -$1.30, which was up 63.89% from -$3.60 recorded in FY2024.
  • In the past 5 years, Twist Bioscience's EPS (Weighted Average and Diluted) ranged from a high of -$1.30 in FY2025 and a low of -$4.04 during FY2022.
  • Its 3-year average for EPS (Weighted Average and Diluted) is -$2.83, with a median of -$3.60 in 2024.
  • In the last 5 years, Twist Bioscience's EPS (Weighted Average and Diluted) decreased by 28.25% in 2022 and then surged by 63.89% in 2025.
  • Yearly analysis of 5 years shows Twist Bioscience's EPS (Weighted Average and Diluted) stood at -$3.15 in 2021, then decreased by 28.25% to -$4.04 in 2022, then grew by 10.89% to -$3.60 in 2023, then remained steady at -$3.60 in 2024, then skyrocketed by 63.89% to -$1.30 in 2025.